Sigyn Therapeutics, Inc. (OTCMKTS:SIGY) Sees Large Increase in Short Interest

Sigyn Therapeutics, Inc. (OTCMKTS:SIGY) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 1,994 shares. Based on an average daily volume of 13,955 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.4% of the company’s stock are sold short.

Sigyn Therapeutics Stock Performance

OTCMKTS SIGY opened at $0.03 on Friday. The stock has a market cap of $70,612.00, a price-to-earnings ratio of -0.01 and a beta of -0.04. The business has a 50 day simple moving average of $0.03 and a 200 day simple moving average of $0.12. Sigyn Therapeutics has a 52-week low of $0.01 and a 52-week high of $2.00.

About Sigyn Therapeutics

Sigyn Therapeutics, Inc is a biotechnology and medical device company focused on developing therapeutic solutions for cancer and pathogen-associated diseases. The company’s primary technology is designed to address conditions in which harmful pathogens and excessive inflammatory signaling contribute to disease progression.

Its lead product candidate, Sigyn Therapy, is an extracorporeal blood-purification technology intended to remove circulating pathogens and inflammatory cytokines from a patient’s blood.